(ZEPP) Zepp Health - Ratings and Ratios
Smart Bands, Watches, Scales, Rings, Hearables
ZEPP EPS (Earnings per Share)
ZEPP Revenue
Description: ZEPP Zepp Health
Zepp Health Corporation is a global smart wearable and health technology company that empowers users to optimize their health, fitness, and wellness journeys through its consumer brands, including Amazfit, Zepp Clarity, and Zepp Aura. By leveraging its proprietary Zepp Digital Management Platform, the company provides cloud-based, 24/7 actionable insights and guidance to help users achieve their wellness goals. With a diverse product portfolio that includes smart bands, watches, scales, rings, and associated accessories, Zepp Health Corporation has established a significant presence in the global wearables market, operating in approximately 90 countries.
The companys product ecosystem is designed to provide a holistic approach to health and wellness, with features such as real-time, personalized sound health solutions through Zepp Aura, and data analysis through its Zepp Life and Zepp mobile apps. Zepp Health Corporations commitment to innovation is reflected in its proprietary AI chips, biometric sensors, and data algorithms, which enable the delivery of high-quality, data-driven insights to its users. With a history dating back to 2013, the company has evolved from its origins as Huami Corporation to become a leading player in the global wearables market.
From a technical analysis perspective, ZEPPs stock price is currently trading near its 52-week low, with a last price of $2.66. The stocks short-term and long-term moving averages (SMA20, SMA50, and SMA200) suggest a downtrend, with the stock price below its 200-day moving average. However, the Average True Range (ATR) indicates a relatively low volatility, which could be a sign of stabilization. Considering the fundamental data, the companys market capitalization stands at $38.22M USD, with a forward P/E ratio of 3.12, suggesting a relatively low valuation. Despite a negative Return on Equity (RoE) of -58.22, the companys focus on innovation and expanding its product portfolio could potentially drive future growth.
Based on the technical and fundamental data, a possible forecast for ZEPP is that the stock price may continue to consolidate in the short term, potentially trading within a range of $2.40-$2.80. However, if the company can demonstrate significant growth in its revenue and user base, driven by its innovative products and expanding global presence, the stock price could potentially break out above its 52-week high of $4.35 in the long term. Conversely, if the company fails to deliver on its growth promises, the stock price could continue to decline, potentially testing new lows. A key level to watch is the $2.50 support level, as a break below this level could lead to further downside, while a bounce off this level could indicate a potential reversal.
Additional Sources for ZEPP Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
ZEPP Stock Overview
Market Cap in USD | 43m |
Sector | Technology |
Industry | Consumer Electronics |
GiC Sub-Industry | Electronic Equipment & Instruments |
IPO / Inception | 2018-02-08 |
ZEPP Stock Ratings
Growth Rating | -80.4 |
Fundamental | -70.1 |
Dividend Rating | 1.0 |
Rel. Strength | 66.9 |
Analysts | 5 of 5 |
Fair Price Momentum | 1.77 USD |
Fair Price DCF | - |
ZEPP Dividends
Currently no dividends paidZEPP Growth Ratios
Growth Correlation 3m | -0.6% |
Growth Correlation 12m | -24% |
Growth Correlation 5y | -96.5% |
CAGR 5y | -40.48% |
CAGR/Max DD 5y | -0.42 |
Sharpe Ratio 12m | -0.04 |
Alpha | 79.78 |
Beta | 0.540 |
Volatility | 68.38% |
Current Volume | 15102.1k |
Average Volume 20d | 17.5k |
Stop Loss | 4.8 (-6.3%) |
As of July 10, 2025, the stock is trading at USD 5.12 with a total of 15,102,057 shares traded.
Over the past week, the price has changed by +81.56%, over one month by +112.45%, over three months by +135.40% and over the past year by +88.79%.
No, based on ValueRay´s Fundamental Analyses, Zepp Health (NYSE:ZEPP) is currently (July 2025) a stock to sell. It has a ValueRay Fundamental Rating of -70.13 and therefor a negative outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ZEPP is around 1.77 USD . This means that ZEPP is currently overvalued and has a potential downside of -65.43%.
Zepp Health has received a consensus analysts rating of 5.00. Therefore, it is recommended to buy ZEPP.
- Strong Buy: 1
- Buy: 0
- Hold: 0
- Sell: 0
- Strong Sell: 0
According to our own proprietary Forecast Model, ZEPP Zepp Health will be worth about 1.9 in July 2026. The stock is currently trading at 5.12. This means that the stock has a potential downside of -62.7%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 12.3 | 140.6% |
Analysts Target Price | 12.3 | 140.6% |
ValueRay Target Price | 1.9 | -62.7% |